Publications [#381293] of Seog Oh

Papers Published

1. Myu Mai Ja, KP; Lim, KP; Chen, A; Ting, S; Li, SQ; Tee, N; Ramachandra, C; Mehta, A; Wong, P; Oh, S; Shim, W, Construction of a vascularized hydrogel for cardiac tissue formation in a porcine model., Journal of tissue engineering and regenerative medicine, vol. 12 no. 4 (April, 2018), pp. e2029-e2038 [doi]
   (last updated on 2026/01/20)

   Abstract:
   Replacing cardiac tissues lost to myocardial infarction remains a therapeutic goal for regenerative therapy in recovering cardiac function. We assessed the feasibility of constructing a macrosized human cardiac tissue construct using pluripotent stem cell-derived cardiomyocytes or control fibroblasts infused fibrin/collagen hydrogel and performed ectopic implantation in peripheral vascular system of a porcine model for 3 weeks. Finally, an optimized vascularized cardiac construct was explanted and grafted onto porcine myocardium for 2 weeks. Myocardial-grafted human cardiac constructs showed a nascent tissue-like organization with aligned cardiomyocytes within the remodelled collagen matrix. Nevertheless, no significant changes in intraconstruct density of cardiomyocytes were observed in the myocardial-grafted constructs (human embryonic stem cell [hESC]-derived cardiomyocyte [n = 4]: 70.5 ± 22.8 troponin I⁺ cardiomyocytes/high power field [HPF]) as compared to peripherally implanted constructs (hESC-derived cardiomyocyte [n = 4]: 59.0 ± 19.6 troponin I⁺ cardiomyocytes/HPF; human induced pluripotent stem cell-derived cardiomyocyte [n = 3]: 50.9 ± 8.5 troponin I⁺ cardiomyocytes/HPF, p = ns). However, the myocardial-grafted constructs showed an increased in neovascularization (194.4 ± 24.7 microvessels/mm² tissue, p < .05), microvascular maturation (82.8 ± 24.7 mature microvessels/mm² , p < .05), and tissue-like formation whereas the peripherally implanted constructs of hESC-derived cardiomyocyte (168.3 ± 98.2 microvessels/mm² tissue and 68.1 ± 33.4 mature microvessels/mm² ) and human induced pluripotent stem cell-derived cardiomyocyte (86.8 ± 57.4 microvessels/mm² tissue and 22.0 ± 32.7 mature microvessels/mm² ) were not significantly different in vascularized response when compared to the control human fibroblasts (n = 3) constructs (65.6 ± 34.1 microvessels/mm² tissue and 30.7 ± 20.7 mature microvessels/mm² ). We presented results on technical feasibility and challenges of grafting vascularized centimetre-sized human cardiac construct that may spur novel approaches in cardiac tissue replacement strategy.